ArticleBlood advances2026

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma.

Grace Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.